From: Packaging News

ULMA Packaging is promoting its machinery which complies with the Falsified Medicines Directive (FMD).

The UK Government has confirmed that Brexit will not put a stop to its plans to implement FMD in February 2019.

This legislation imposes two mandatory safety demands on packs of medical products – a unique identifier barcode to ensure full traceability and tamper evident features to assure patients that their medicines have not been interfered with.

ULMA said its equipment can incorporate different labelling and coding systems to ensure traceability data is transparent across the entire logistics chain, as well as creating tamper-proof packaging, such as blister packs and shrink wrapping, for the maximum protection of healthcare products.

Each ULMA solution can be issued with an internal validation document that connects with the customer’s specification, and which is constantly cross-referenced during the testing and setting up of the equipment to ensure compatibility with all requirements.

It can supply thermoformers, flow packs, fill and seal technology, traysealing, blister, shrink wrapping and sleeve wrapping, matched by a diverse range of plastic films, medical grade paper, Tyvek and aluminised materials to safeguard against mis-handling and contamination.

Martin Baldwin, ULMA’s thermoformer business manager in the UK and Ireland, said: “We have huge experience in meeting the strictest standards laid down by the pharmaceutical and medical sectors. Our diverse packaging technology addresses the challenges posed by legislation designed to improve protection and preserve tough sterilisation conditions of healthcare products.”